COMMUNIQUÉS West-GlobeNewswire

Rafael Pharmaceuticals to Present at BIO Investor Forum 2018

09/10/2018 - 14:55

Newark, NJ, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that Sanjeev Luther, its President and Chief Executive [...]

CV Sciences, Inc.’s PlusCBD Oil™ featured on Oct. 3rd Episode of ‘The Dr. Oz Show’

09/10/2018 - 14:45

PlusCBD Oil™ Capsules featured as one of the industry-leading in efficacy and strength; Dr. Oz segment cites sales of CBD products expected to increase 700% over the next year LAS VEGAS, Oct. 09, 2018 (GLOBE NEWSWIRE [...]

Genocea Announces Upcoming Presentations at SITC 2018

09/10/2018 - 14:35

Posters showcase ability of ATLAS™ platform to identify neoantigens for inclusion in and exclusion from personalized immunotherapies CAMBRIDGE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ [...]

Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial

09/10/2018 - 14:30

CALGARY, Alberta, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM) is pleased to announce that it has received all approvals from three new medical centers to be [...]

Arbutus Provides Update on HBV Development Programs and Announces Appointment of Dr. Gaston Picchio as Chief Development Officer

09/10/2018 - 14:30

Dr. Mark Murray, Arbutus President & Chief Executive Officer, to participate in a fireside chat at Chardan’s Genetic Medicines Conference at 2:45 pm ET today WARMINSTER, Pa., Oct. 09, 2018 (GLOBE NEWSWIRE) -- [...]

New Data from Adult ADHD Clinical Trial to be Presented at the 65th Annual AACAP Meeting

09/10/2018 - 14:30

Prof. Stephen Faraone, Ph.D. to present on October 25 in Seattle, Washington COLUMBIA, Md., Oct. 09, 2018 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Inc., and leader in developing specialty [...]

Ritter Pharmaceuticals Presents Additional Phase 2b Data Showing Adaptation of the Gut Microbiome in Lactose Intolerance Patients at American College of Gastroenterology Scientific Meeting

09/10/2018 - 14:30

LOS ANGELES, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]

CRUZANI Begins Product Development with Cannabis Derivatives for Edible and Infusion Markets

09/10/2018 - 14:30

ATLANTA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- CRUZANI, Inc. (OTC Markets: CZNI) is a global business development company focused on creating and acquiring franchise concepts, along with peripheral food-related businesses [...]

Precision Therapeutics’ Skyline Medical Division Signs International Distribution Agreement with India-based Prenit World

09/10/2018 - 14:30

MINNEAPOLIS, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) is pleased to announce that its Skyline Medical division, producer of the FDA-approved and CE- [...]

Bellerophon Provides Update on INOpulse® Phase 2b Clinical Program for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

09/10/2018 - 14:30

Enrollment of the Planned 40 Subjects Completed, with Top-line Data Expected in January 2019 WARREN, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company [...]

Progenics Announces Publication of Pivotal Trial of AZEDRA® (iobenguane I 131) in The Journal of Nuclear Medicine

09/10/2018 - 14:30

NEW YORK, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]

TESARO Announces Data Presentations at the ESMO 2018 Congress

09/10/2018 - 14:15

WALTHAM, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced that data from six abstracts will be presented at the European Society for [...]

SUNY Upstate Medical University Selects iCAD’s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

09/10/2018 - 14:00

Premier center becomes first in the region to offer intraoperative radiation therapy with the leading-edge Xoft System to advance quality patient care in New York State NASHUA, N.H. and SYRACUSE, N.Y., Oct. 09, 2018 ( [...]

Mapi Pharma Presents Phase II Extension Results of Glatiramer Acetate Depot (GA Depot) at ECTRIMS 2018 in Berlin

09/10/2018 - 14:00

81.8% Patients on GA Depot Demonstrated No Evidence of Disease Activity (NEDA) at 2 years GA Depot Has Potential to Address Multiple Sclerosis Treatment Burden and Improve Patient Compliance NESS ZIONA, Israel, Oct. 09 [...]

Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA

09/10/2018 - 14:00

PRINCETON, N.J., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it has received a response from FDA’s Office of New Drugs (“OND”) concerning [...]

Poseida Therapeutics Appoints Marcy Graham as Vice President, Corporate Affairs

09/10/2018 - 14:00

SAN DIEGO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced Marcy Graham has [...]

Ceapro Inc. Receives Approval from Health Canada to Commence Human Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent

09/10/2018 - 14:00

– Ceapro is Pioneering approach with a natural product as add-on therapy to a prescription product – First of the clinical studies being conducted as part of collaboration with the Montreal Heart Institute led by MHI’s [...]

Oryzon announces first patient enrolled in REIMAGINE: a Phase IIa clinical trial with Vafidemstat (ORY-2001) in aggressiveness

09/10/2018 - 14:00

MADRID, Spain and CAMBRIDGE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), (“Oryzon”), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop [...]

Coherus BioSciences Announces New Employment Inducement Grants

09/10/2018 - 14:00

REDWOOD CITY, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective October 8, 2018, the compensation committee of the company’s board of directors granted 65 [...]